•
Mar 31

Option Care Health Q1 2025 Earnings Report

Financial Results for the First Quarter Ended March 31, 2025

Key Takeaways

Option Care Health reported strong first quarter 2025 financial results, demonstrating significant year-over-year growth in net revenue, gross profit, net income, adjusted net income, and adjusted EBITDA, driven by solid execution.

Net revenue increased by 16.3% to $1,333.0 million compared to the first quarter of 2024.

Adjusted EBITDA grew by 13.7% to $111.8 million.

Adjusted diluted earnings per share rose by 14.3% to $0.40.

The company's net cash used in operating activities significantly decreased to $7.2 million compared to $68.8 million in the prior year period.

Total Revenue
$1.33B
Previous year: $1.15B
+16.3%
EPS
$0.4
Previous year: $0.26
+53.8%
Adjusted EBITDA
$112M
Previous year: $98.3M
+13.7%
Cash Used in Operations
-$7.21M
Previous year: -$68.8M
-89.5%
Gross Profit
$263M
Previous year: $239M
+10.3%
Cash and Equivalents
$171M
Previous year: $220M
-21.9%
Free Cash Flow
-$16.6M
Previous year: -$74.6M
-77.8%
Total Assets
$3.31B
Previous year: $3.25B
+1.8%

Option Care Health

Option Care Health

Forward Guidance

For the full year 2025, Option Care Health expects net revenue between $5.4 billion and $5.6 billion, adjusted diluted earnings per share between $1.61 and $1.70, adjusted EBITDA between $455 million and $470 million, and cash flow from operations of at least $320 million.

Positive Outlook

  • Expected full-year 2025 net revenue between $5.4 billion and $5.6 billion.
  • Expected full-year 2025 adjusted diluted earnings per share between $1.61 and $1.70.
  • Expected full-year 2025 adjusted EBITDA between $455 million and $470 million.
  • Expected full-year 2025 cash flow from operations of at least $320 million.
  • Expects 2025 to be a productive year with continued investment for future growth.

Challenges Ahead

  • No specific negative aspects of the guidance were provided.
  • No specific negative aspects of the guidance were provided.
  • No specific negative aspects of the guidance were provided.
  • No specific negative aspects of the guidance were provided.
  • No specific negative aspects of the guidance were provided.